Colorectal Cancer Prognosis

Prognosis of outcome of a cancer is usually determined by several parameters. Some of these include survival rates, expectation of survival for at least 5 years after diagnosis, survival without progression of the disease or cancer (termed progression free survival) etc.

5-year survival rates

The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Many patients may and do survive much longer than 5 years especially if the cancer is detected early.

Survival rates are often based on previous outcomes of large numbers of people who had the disease. They are an estimate and cannot predict the actual survival estimate in an individual.

Colon cancer survival rates

In colon cancer survival rates are predicted by stage.

This comes from a study of the National Cancer Institute's SEER database, looking at more than 28,000 people diagnosed with colon cancer between 1998 and 2000.

Stage 1 – 74% 5-year Survival Rate
Stage 2A – 67% 5-year Survival Rate
Stage 2B – 59% 5-year Survival Rate
Stage 2C – 37% 5-year Survival Rate
Stage 3A – 73% 5 year survival rate
Stage 3B – 46% 5-year Survival Rate
Stage 3C - 28%5-year Survival Rate
Stage 4 - 6% 5-year Survival Rate

*In this study, survival was better for some stage III cancers than for some stage II cancers. The reasons for this are not clear.

Rectum cancer survival rates

In rectum cancer survival rates are predicted by stage.

These survival rates are based on a study of the National Cancer Institute's SEER database, looking at nearly 10,000 people diagnosed with rectal cancer between 1998 and 2000.

Stage 1 – 74% 5-year Survival Rate
Stage 2A – 65% 5-year Survival Rate
Stage 2B – 52% 5-year Survival Rate
Stage 2C – 32% 5-year Survival Rate
Stage 3A – 74% 5 year survival rate
Stage 3B – 45% 5-year Survival Rate
Stage 3C - 33%5-year Survival Rate
Stage 4 - 6% 5-year Survival Rate

*In this study, survival was better for some stage III cancers than for some stage II cancers. The reasons for this are not clear.

Further Reading

Last Updated: Jul 18, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 18). Colorectal Cancer Prognosis. News-Medical. Retrieved on July 19, 2024 from https://www.news-medical.net/health/Colorectal-Cancer-Prognosis.aspx.

  • MLA

    Mandal, Ananya. "Colorectal Cancer Prognosis". News-Medical. 19 July 2024. <https://www.news-medical.net/health/Colorectal-Cancer-Prognosis.aspx>.

  • Chicago

    Mandal, Ananya. "Colorectal Cancer Prognosis". News-Medical. https://www.news-medical.net/health/Colorectal-Cancer-Prognosis.aspx. (accessed July 19, 2024).

  • Harvard

    Mandal, Ananya. 2023. Colorectal Cancer Prognosis. News-Medical, viewed 19 July 2024, https://www.news-medical.net/health/Colorectal-Cancer-Prognosis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Cellular immunotherapy offers hope for solid tumors